News | Business | October 05, 2017

BTG Acquires Roxwood Medical

Acquisition allows BTG to further expand interventional vascular portfolio

BTG Acquires Roxwood Medical

October 5, 2017 — BTG plc announced it has acquired Roxwood Medical, provider of advanced cardiovascular specialty catheters used in the treatment of patients with severe coronary and peripheral artery disease.

Roxwood's anchoring catheters (CenterCross, CenterCross Ultra, MultiCross) and microcatheters (MicroCross) offer options for physicians in the crossing of complex lesions and arterial blockages. By incorporating a self-expanding scaffold that stabilizes the delivery of a guidewire, Roxwood’s catheters provide positioning accuracy and support to facilitate the crossing of blockages, mitigating guidewire buckling and enabling treatments such as angioplasty, stenting or atherectomy.

“This bolt-on acquisition continues to build BTG’s strength in the interventional vascular space, further expanding our portfolio of differentiated minimally invasive vascular technologies,” said John Sylvester, BTG’s chief commercial officer. “Roxwood’s products complement our existing business and will be offered through our existing EKOS hospital sales force, providing our customers with options to enable treatment of these patients with complex lesions.”

“This is an exciting new chapter for the team at Roxwood and further testament to the utility of the anchoring and microcatheter platforms,” said Mehrdad Farhangnia, Roxwood’s chief executive officer. “With the expanded commercial and clinical reach of BTG, these minimally invasive tools can help far more clinicians successfully treat patients with severe arterial blockages.”

BTG will pay up to $80 million in cash to acquire Roxwood, comprising $65 million paid on closing and up to an additional $15 million should certain future commercial milestones be achieved. The transaction is expected to be accretive to adjusted EPS from the second full year of ownership.

For more information: www.btgplc.com

Related Content

FDA Releases Final Rule on Data Acceptance from Medical Device Clinical Investigations
News | Business | February 21, 2018
The U.S. Food and Drug Administration (FDA) issued the final rule on “Human Subject Protection; Acceptance of Data from...
Amazon, Berkshire Hathaway and JPMorgan Chase to Form New Healthcare Company
News | Business | January 30, 2018
January 30, 2018 — Amazon , Berkshire Hathaway and JPMorgan Chase & Co.
News | Business | January 16, 2018
American College of Cardiology (ACC) Chief Executive Officer Shalom “Shal” Jacobovitz will be leaving the College...
CMS Launches New Voluntary Bundled Payments Model
News | Business | January 10, 2018
The Centers for Medicare & Medicaid Services (CMS) Center for Medicare and Medicaid Innovation (Innovation Center)...
Toshiba Medical Systems Changes Name to Canon Medical Systems Corp.
News | Business | January 08, 2018
January 8, 2018 — Canon Inc. and Canon Medical Systems Corp.
CMS Announces Final Changes, Cancellations of Mandatory Bundled Payment Models
News | Business | December 21, 2017
The Centers for Medicare & Medicaid Services (CMS) last week finalized the cancellation of the mandatory hip...
Catheter reprocessing can reduce costs in the cath and EP lab.
Feature | Business | December 19, 2017 | Lars Thording
As payers and other healthcare entities look to better manage costs, especially in the acute care setting, it is impo
FDA Issues Final Guidance on Investigational Device Exemption Categorization
News | Business | December 19, 2017
The U.S. Food and Drug Administration (FDA) recently issued a final guidance, “FDA Categorization of Investigational...
Congressional Budget Office Finds cutting ACA insurance mandate will cause 13 million people to become uninsured, higher insurance premiums. American Heart Association (AHA), #AHA2017
News | Business | December 06, 2017
December 6, 2017 — At the American Heart Association (AHA) annual meeting in November, a group of 16 non-partisan pat
5 Tips for Medical Device Engineers on FDA Design Controls
Feature | Business | November 24, 2017 | Jon Speer
If you are an engineer in the medical device industry, you probably have a love/hate relationship with the FDA-mandat
Overlay Init